Endosense(瑞士)

Endosense

Endosensewww.endosense.comEndosense于2003年在日内瓦成立，是一家医疗科技公司，致力于改善治疗心律失常的导管消融术的功效、安全性和易用性。公司在开发TactiCath*时率先在导管消融术中采用了触点压力测量，TactiCath是种压敏消融导管，允许医生在实施导管消融术时实时、客观地测量接触力。Endosense得到EdmonddeRothschildInvest mentPartners、Neomed、Gimv、VIPartners、SectoralAssetManagement、YsiosCapitalPartners及InitiativeCapitalRomandie等投资公司的投资支持。Endosenseisamedicaltechnologycompanyfocusedonimprovingtheefficacy,safetyandreproducibilityofcatheterablationforthetreatmentofcardiacarrhythmias.ThecompanyhaspioneeredtheuseofContactForceincatheterablation.Thecompany’sflagshipproductistheTactiCathQuartz®,thefirstforce-sensingablationcathetertogivephysiciansareal-time,objectivemeasureofcontactforceduringthecatheterablationprocedure.AlreadydistributedinEurope,AustraliaandNewZealand,thisforce-sensingcatheterhasundergoneextensivepre-clinicalandclinicalvalidation.Endosense’star